Bioavailability of Fatty Acids From Krill Oil and Krill Meal and Fatty Acids From Fish Oil in Healthy Subjects.
Phase 2
Completed
- Conditions
- Healthy
- Interventions
- Dietary Supplement: Krill oilDietary Supplement: Krill mealDietary Supplement: Fish oil
- Registration Number
- NCT02089165
- Lead Sponsor
- Olympic Seafood AS
- Brief Summary
The purpose of the study is to compare the acute bioavailability of two different krill oil products called krill oil and krill meal in comparison to fish oil product.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
- Healthy female and male
- Age 18 - 65 years
- Body mass index 18.5 - 30
- Informed consent, signed
Exclusion Criteria
- Medication potential to affect the bioavailability of fatty acids (e.g. lipid-lowering drugs)
- Familial hypercholesterolemia, marked combined hyperlipidemia, condition that would impair, fat absorption (e.g. chronic pancreatitis, pancreatic lipase deficiency syndrome)
- Any untreated medical condition affecting absorption of fat
- Type 1 and 2 diabetes
- Cancer or other malignant disease within past five years
- Periodical hormone replacement therapy
- High intake of oily fish (once a week or more) (i.e. salmon, herring, sardines, mackerel, vendace)
- Smoking
- Alcohol consumption > 15 doses per week
- Females who are pregnant, breast-feeding or intend to become pregnant
- Hypersensitivity to any of the components of the test product
- Regular use of n-3 supplements 4 weeks before randomization
- Lack of suitability for participation in the trial, for any medical reason, as judged by the principal investigator
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Krill oil Krill oil The interventions are administered in the randomized order. Krill meal Krill meal The interventions are administered in the randomized order. Fish oil Fish oil The interventions are administered in the randomized order.
- Primary Outcome Measures
Name Time Method Incremental 0-72 h area under the curve of EPA + DHA proportion in plasma phospholipids. 0-72 h
- Secondary Outcome Measures
Name Time Method Incremental 0-72 h area under the curve of EPA + DHA proportion in plasma triglyceride. 0-72 h
Trial Locations
- Locations (1)
Oy Foodfiles Ltd, memeber of Foodfiles group
🇫🇮Kuopio, Finland